Stay updated with breaking news from Proprietary Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In a significant move within the pharmaceutical industry, CEO Michael Castagna has parted with a substantial number of shares in MannKind Corp (NASDAQ:MNKD).
CytoMed Therapeutics Limited (NASDAQ: GDTC) ("CytoMed" or "Company"), a Singapore-based biopharmaceutical company focused on harnessing its proprietary technologies to develop novel donor-derived cell-based allogeneic immunotherapies for the treatment of various cancers, today announced that its exclusively licensed induced pluripotent stem cell (iPSC)-based technology has been granted a patent by the China National Intellectual Property Administration (CNIPA).
It has been a busy past few months for Australian battery recycling technology startup Battery Pollution Technologies.
More Than 600 Bispecific, Trispecific & Tetra Specific Antibodies Are In Clinical Trials Says Kuick Research In New Reports...
This article outlines the essential steps on how to start an IT consulting business. Read on to learn how to start a consulting business.